Cowen and Company’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-47,500
Closed -$4.96K 628
2024
Q1
$4.96K Hold
47,500
﹤0.01% 574
2023
Q4
$16.6K Hold
47,500
﹤0.01% 355
2023
Q3
$10.9K Sell
47,500
-500
-1% -$235 ﹤0.01% 449
2023
Q2
$30.4K Buy
+48,000
New +$21.5K ﹤0.01% 296
2020
Q4
Sell
-141,698
Closed -$173K 417
2020
Q3
$173K Buy
141,698
+78,752
+125% +$85.1K 0.03% 224
2020
Q2
$57K Sell
62,946
-9,250
-13% -$6.59K 0.01% 277
2020
Q1
$53K Buy
+72,196
New +$67.4K 0.01% 277

Other funds holding SRTAW

Cowen and Company's SRTAW Position: Q2 2024 in Review

Cowen and Company sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2024, closing a stake of 47,500 shares — an estimated $4.96K sold.

Cowen and Company first reported a position in SRTAW in Q1 2020 and held it in 7 quarters. The position peaked at $173K in Q3 2020. 11 funds tracked by Wall St. Rank hold SRTAW as of Q2 2024.

  • Cowen and Company reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2024 after selling out during the quarter.
  • Cowen and Company sold 47,500 Strata Critical Medical Inc Warrants shares in Q2 2024, an estimated $4.96K.
  • Cowen and Company first reported a position in Strata Critical Medical Inc Warrants in Q1 2020 and held it in 7 quarters.
  • Cowen and Company's Strata Critical Medical Inc Warrants position peaked at $173K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2024.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.